Acylpeptide hydrolase (APH) catalyzes the N-terminal hydrolysis of N α -acylpeptides to release N α -acylated amino acids. The crystal structure of recombinant APH from the thermophilic archaeon Aeropyrum pernix K1 (apAPH) was reported recently to be at a resolution of 2.1 Å using X-ray diffraction. A truncated mutant of apAPH that lacks the first short α-helix at the N-terminal, apAPH-∆(1-21), was cloned, expressed, characterized and crystallized. Data from biochemical experiments indicate that the optimum temperature of apAPH is decreased by 15 °C with the deletion of the N-terminal α-helix. However, the enzyme activity at the optimal temperature does not change. It suggests that this N-terminal α-helix is essential for thermostability. Here, the crystal structure of apAPH-∆(1-21) has been determined by molecular replacement to 2.5 Å. A comparison between the two structures suggests a difference in thermostability, and it can be concluded that by adding or deleting a linking structure (located over different domains), the stability or even the activity of an enzyme can be modified.
Acylpeptide hydrolase (APH; also known as acylamino acid-releasing enzyme or acylaminoacyl peptidase [EC3. 4.19 .1]), a member of the prolyl oligopeptidase family of serine proteases, catalyzes the N-terminal hydrolysis of N α -acylpeptides to release N α -acylated amino acids [1] . In addition to APH, the members of the prolyl oligopeptidase family include dipeptidyl peptidase IV (DPP IV), fibroblast activation protein α, DPP7, DPP8, DPP9, prolyl carboxypeptidase, oligopeptidase B and prolyl oligopeptidase (POP). Most of them are important in the research for new drugs [2, 3] .
To date, rat, porcine, human and bovine APH from various tissues have been characterized. They all consist of 732 amino acids, and are reported to form homotetramers [4] [5] [6] [7] [8] . However, Arabidopsis thaliana APH is a 764-amino acid protein, which exhibits 31.8% sequence identity with rat APH, but it also forms a tetramer [9] . APH has also been found in an organism cell other than a eukaryotic cell. An APH from the thermophilic archaeon Pyrococcus horikoshii OT3 has also been characterized. Being different from its mammalian counterparts, it is 100 residues shorter and forms a homodimer [10] . Inhibition of APH activity leads to apoptosis [11] , and a deficiency in human APH is reported to be linked to small-cell lung carcinoma and renal cell carcinoma [12] [13] [14] . APH in the porcine brain may be the target of the cognitive-enhancing effects of certain organophosphorus compounds [15] .
Like P. horikoshii OT3, Aeropyrum pernix K1 grows in the temperature range of 90 to 98 °C, with an optimal temperature of 95 °C. However, P. horikoshii OT3 is an anaerobic euryarchaeota, but A. pernix K1 is an aerobic strain classified as crenarchaeota. The complete genome of A. pernix K1 has been sequenced, and four genes (Ape1547, Ape1832, Ape2290 and Ape2441) have been designated as encoding APHs [16] . Recently, the crystal structure of an APH from A. pernix K1 (apAPH), the gene product of Ape1547, was determined [17] . This is the first confirmed structure of an APH. Formerly, only human APH has been crystallized, but the structure remains unknown [18] .
apAPH is a symmetric homodimer, and each monomer comprises two domains. The N-terminal domain is a seven-bladed β-propeller and the C-terminal catalytic domain has a canonical α/β hydrolase fold [17] . A short α-helix at the N-terminus (residues 8-23) extends from the β-propeller domain and forms part of the hydrolase domain; this forms a linking structure between these two domains.
To investigate how this N-terminal α-helix affects the whole structure, enzyme activity and thermostability, a mutant of apAPH in which the first 21 amino acids at the N-terminus were removed, apAPH-∆(1-21), was expressed in Escherichia coli, and its crystal structure was determined.
Materials and Methods

Materials
The expression vector pET11a-apAPH-∆(1-21) was constructed by the Key Laboratory of Molecular Enzymology and Engineering of Ministry of Education, Jilin University, China. The E. coli BL21(DE3) strain was obtained from NovagenDarmstadt, Germany, and chromatography columns were purchased from Amersham Pharmacia Biotech (Uppsala Sweden). General reagents were of analytical grade.
Protein expression and purification
The expression vector pET11a-apAPH-∆(1-21) was transformed into the E. coli BL21(DE3) strain. The conditions for expression were as follows. Bacteria were grown in LB medium (10 mg/ml tryptone, 5 mg/ml yeast extract, 10 mg/ml NaCl) containing 100 µg/ml penicillin at 37 °C until A 600 =0.6, then induced with 0.5 mM isopropyl-β-D-thiogalactopyranoside (IPTG). After treatment at 25 °C overnight, the cellswere harvested by centrifugation at 5000 rpm for 10 min, resuspended in 25 mM Tris-HCl (pH 8.0) and 50 mM NaCl, and lysed by sonication. The soluble cell lysate obtained by centrifugation at 15,000 rpm for 30 min was heated at 75 °C for 1 h. Then the supernatant obtained by centrifugation was loaded onto a Q Sepharose fast flow column previously equilibrated with 25 mM Tris-HCl (pH 8.0) and 50 mM NaCl. After washing away the unbound protein with two bed volumes, a linear gradient of 0.05-1 M NaCl in the same buffer was applied. The collected fractions were centrifuged for 30 min at 15,000 rpm. The supernatant was then loaded onto a Resource Q anion-exchange chromatography column equilibrated with 25 mM Tris-HCl (pH 8.0) and 50 mM NaCl. The eluted sample was concentrated using Filtron 5K to 250 µl and loaded onto a Superdex 75 size-exclusion chromatography column. The fraction showing only one protein band with a molecular weight of about 60 kDa after SDS-PAGE was collected and its purity was determined to be suitable for crystallization.
Crystallization
The purified protein was concentrated using Filtron 5K to 25 mg/ml in a solution containing 50 mM NaCl. apAPH crystallization conditions were used for the initial screening using the hanging-drop vapor diffusion method. The mixed drop including 1.5 µl of protein solution and 1.5 µl of reservoir solution was grown in an airtight system containing 0.4 ml of reservoir solution at 18 °C. Crystals appeared after one month with the protein concentration above 25 mg/ml. The best crystallization results were obtained with 4.5%-5% (W/V) PEG 4000, 0.025 M sodium acetate, pH 4.6. To improve the quality of the crystals, 0.025%-0.05% agarose gel was added.
Data collection and processing
The data were collected to 2.5 Å using a 345 mm MAR Research image-plate system mounted on a Rigaku RU-2000 Cu K α rotating-anode generator (Norderstedt, Germany) operated at 48 kV and 98 mA. During data collection, the crystal was maintained at 100 K using a Cryostream (Oxford Cryosystems, Oxford, UK) in a cryoprotectant prepared by adding 20% glycerol to the mother liquor. The data were processed and scaled with DENZO and SCALEPACK.
Results
Structure determination and refinement
The asymmetric unit of the crystal contains two molecules (denoted A and B) with an approximate solvent content of 44%. The structure of apAPH-∆(1-21) was determined by molecular replacement with the program AMoRe, using the known structure of apAPH (PDB code 1VE6) as a search model. The program O was used for viewing electron density maps and manual building. Crystallography & NMR System (CNS) was used for refinement, with iterative cycles of simulated annealing and individual B-factor refinement in the resolution range of 50-2.5 Å. The final structure had R work =22.9% (R free =24.8%) and consisted of residues 1-561 in both molecule A and molecule B and 579 water molecules. From the Ramachandran plot generated by PROCHECK, the final structure was found to have good stereochemistry, with 73.8% of residues in the most favored region, 26% of residues in the additionally allowed region and 0.2% of residues in the generously allowed region. The final refinement statistics for the model are given in Table 1 . Table 1 Data set and refinement statistics 
Comparison with apAPH
Enzymatic assay data indicate that the optimum temperature of apAPH is decreased by 15 °C (from 90 °C to 75 °C) with the deletion of the N-terminal α-helix, but the enzyme activity at the optimal temperature does not change (data not shown). It suggests that this α-helix is be essential for thermostability. Fig. 1 shows the 2 for apAPH respectively. It should be noted that the temperature factors are considerably higher for apAPH-∆(1-21), indicating greater mobility along the polypeptide chain in this structure (Fig. 2) .
Analysis of the electrostatic surface of apAPH-∆(1-21) revealed that an additional cavity forms where the N-terminal α-helix existed (Fig. 3) . It is believed that the cavity in the electrostatic surface is a disadvantage for protein stability. The circled regions represent the cavity.
Discussion
apAPH is a bifunctional enzyme, acting as both APH and esterase. Esterases have developed into the most widely used class of enzymes in various industrial processes, finding use in stereospecific hydrolysis, transesterification, ester synthesis and modification of physicochemical properties of triglycerides for fat biosynthesis and other organic biosynthesis reactions. However, mesophilic enzymes are often not well suited for the harsh reaction conditions (such as high temperature, exposure to organic solvents, etc.) in industrial processes because of the lack of enzyme stability. The discovery of a specific esterase able to function under extreme conditions is important and will widely extend the range of reactions in which esterase can be used. Experiments indicate that apAPH has esterase activity in the temperature range of 55 to 95 °C, with maximum activity and high hyperthermostability at 90 °C (data not shown).
In general, several factors are known to affect the stability of thermophilic proteins. Primary sequence composition, salt bridge/ion pairs and hydrogen bonds, hydrophobic interaction contact area and solvent accessible surface area all contribute to thermostability. In this study, a specific method has been applied and as a result of this, a new method of changing the thermostability of an enzyme to a great extent has been discovered.
In contrast with the percentage of the first 21 amino acids in the total of 582 amino acids (3.6%), the percentages of charged and hydrophobic residues in the truncated sequence are 5.1% and 5.2% respectively. Macroscopically, an increase in the number of charged and hydrophobic residues can enhance thermostability. In addition, there are two important salt bridges (D15-R355 and R18-D325) which also improve the thermal stability. In general, it is believed that a decrease in the solvent-accessible surface area is favorable for protein stability, and the larger cavity results in an increase in solvent accessibility of the structure and thus improves thermostability. But these values are 20,955 Å 2 for apAPH and 20,289 Å 2 for apAPH-∆(1-21). Therefore, the cavity may influence thermostability in other ways.
In conclusion, the decrease in thermostability appears to the result of amino acid composition, fewer ionic interactions and a larger cavity in the structure. Together, these structural features may serve to enhance the thermostability of apAPH. However, as the N-terminal α-helix has no effect on the active site, the enzyme activity of apAPH-∆(1-21) is the same as that of the wild-type apAPH. Moreover, the structural comparison above suggests that we can change the stability of an enzyme and at the same time retain its activity by adding or deleting a linking structure (located over different domains). A quick modification based on structure is thus possible.
